SG11201707332XA - Detection of brain injury - Google Patents

Detection of brain injury

Info

Publication number
SG11201707332XA
SG11201707332XA SG11201707332XA SG11201707332XA SG11201707332XA SG 11201707332X A SG11201707332X A SG 11201707332XA SG 11201707332X A SG11201707332X A SG 11201707332XA SG 11201707332X A SG11201707332X A SG 11201707332XA SG 11201707332X A SG11201707332X A SG 11201707332XA
Authority
SG
Singapore
Prior art keywords
detection
brain injury
brain
injury
Prior art date
Application number
SG11201707332XA
Other languages
English (en)
Inventor
Sarjubhai A Patel
Thomas F Rau
Original Assignee
The Univ Of Montana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Univ Of Montana filed Critical The Univ Of Montana
Publication of SG11201707332XA publication Critical patent/SG11201707332XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201707332XA 2015-03-26 2015-09-22 Detection of brain injury SG11201707332XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/669,454 US9605315B2 (en) 2014-03-26 2015-03-26 Detection of traumatic brain injury
PCT/US2015/051518 WO2016153549A1 (en) 2015-03-26 2015-09-22 Detection of brain injury

Publications (1)

Publication Number Publication Date
SG11201707332XA true SG11201707332XA (en) 2017-10-30

Family

ID=56979279

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201707332XA SG11201707332XA (en) 2015-03-26 2015-09-22 Detection of brain injury

Country Status (11)

Country Link
US (3) US9605315B2 (https=)
EP (1) EP3274008B1 (https=)
JP (1) JP2018518147A (https=)
CN (1) CN107427614B (https=)
AU (2) AU2015387481B2 (https=)
CA (1) CA2976347A1 (https=)
CL (1) CL2017002420A1 (https=)
ES (1) ES3014311T3 (https=)
IL (1) IL253889A0 (https=)
SG (1) SG11201707332XA (https=)
WO (1) WO2016153549A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2833389C (en) 2011-04-18 2022-01-11 Diamir, Llc Mirna-based universal screening test (ust)
JP6930832B2 (ja) 2013-11-18 2021-09-01 ディアミール, エルエルシーDiamir, Llc パーキンソン病(PD)の検出およびモニタリングのための、体液からのmiRNAを使用する方法
EP4328324B1 (en) * 2015-11-18 2026-03-25 Dignity Health Methods of diagnosing epilepsy
US10975436B2 (en) 2016-01-05 2021-04-13 Diamir, Llc Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders
GB201603967D0 (en) 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
US11149313B2 (en) 2016-03-21 2021-10-19 Diamir, Llc Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases
CN108300788B (zh) * 2017-01-13 2021-07-09 中国人民解放军南京军区南京总医院 一种用于检测轻型脑外伤的微小核糖核酸组合及其应用
AU2018240473B2 (en) * 2017-03-23 2023-12-14 Penn State Research Foundation Analysis and prediction of traumatic brain injury and concusion symptoms
US10781487B2 (en) 2017-07-24 2020-09-22 Diamir, Llc miRNA-based methods for detecting and monitoring aging
WO2019232422A1 (en) 2018-05-31 2019-12-05 Amydis, Inc. Compositions and methods for detection of traumatic brain injury
AU2024329035A1 (en) * 2023-08-21 2026-04-02 Glia Diagnostics Pty Ltd Methods and reagents for diagnosis and/or prognosis of traumatic brain injury
CN118314963B (zh) * 2023-11-13 2024-10-29 中国人民解放军空军特色医学中心 一种基于lasso回归的血小板储存损伤风险预测模型及其构建方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145209A0 (en) * 2000-09-06 2002-06-30 Pfizer Prod Inc Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
WO2003103583A2 (en) 2002-06-10 2003-12-18 Oklahoma Medical Research Foundation A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
EP2271931A4 (en) * 2008-04-25 2011-10-12 Merck Sharp & Dohme MICRO-RNA BIOMARKERS FOR TISSUE INJURIES
WO2011032155A2 (en) * 2009-09-14 2011-03-17 Banyan Biomarkers, Inc. Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
US9297007B2 (en) * 2010-05-28 2016-03-29 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg miRNAs involved in the blood brain barrier function
TW201231671A (en) * 2011-01-28 2012-08-01 Univ Kaohsiung Medical Method and kit for in vitro diagnosis of atherosclerosis
WO2013032962A2 (en) 2011-08-28 2013-03-07 The Board Of Trustees Of The Leland Stanford Junior University Micro rnas to treat stroke, ischemic brain injury, traumatic brain injury, and neurodegenerative disease
AU2012308092A1 (en) * 2011-09-13 2014-04-17 Commonwealth Scientific And Industrial Research Organisation Detection of viral infection
WO2013122778A1 (en) * 2012-02-15 2013-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating and preventing diseases and disorders of the central nervous system
US9101580B2 (en) * 2012-12-18 2015-08-11 Matthew Bennett Compositions and methods for treating traumatic brain injury

Also Published As

Publication number Publication date
AU2021258088B2 (en) 2024-11-28
AU2015387481A1 (en) 2017-08-03
EP3274008B1 (en) 2024-12-04
AU2021258088A1 (en) 2021-11-25
AU2015387481B2 (en) 2021-08-05
CA2976347A1 (en) 2016-09-29
WO2016153549A1 (en) 2016-09-29
US10815529B2 (en) 2020-10-27
EP3274008A4 (en) 2018-10-24
US20170268058A1 (en) 2017-09-21
IL253889A0 (en) 2017-10-31
JP2018518147A (ja) 2018-07-12
ES3014311T3 (en) 2025-04-21
CN107427614B (zh) 2021-10-15
EP3274008A1 (en) 2018-01-31
US20190352716A1 (en) 2019-11-21
US10202649B2 (en) 2019-02-12
US20150344954A1 (en) 2015-12-03
CL2017002420A1 (es) 2018-07-13
EP3274008C0 (en) 2024-12-04
CN107427614A (zh) 2017-12-01
US9605315B2 (en) 2017-03-28

Similar Documents

Publication Publication Date Title
ZA201802905B (en) Drowsiness onset detection
ZA201608889B (en) Residence structures and related methods
GB201701673D0 (en) Methods of well treatment
IL246861A0 (en) Passive separation of whole blood
SG11201707332XA (en) Detection of brain injury
SG11201706729SA (en) Derivatives of sobetirome
GB201617843D0 (en) Detection of lane-splitting motorcycles
IL293712A (en) Methods for treating mild brain injury
PL3964213T3 (pl) Leczenie zaburzeń zachowania
GB2545480B (en) Detection of coordinated cyber-attacks
GB201410116D0 (en) Method of treatment
IL251262A0 (en) Methods for treating traumatic brain injury
IL257908A (en) Methods for the treatment of epilepsy
GB201416832D0 (en) Methods of treatment
GB201604627D0 (en) Improved method of FT-IMS
IL250658A0 (en) Methods for treating mild brain injury
GB201513188D0 (en) Method of tomography
GB201509658D0 (en) Method of diagnosis
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201616639D0 (en) Identification of products
GB201512139D0 (en) Methods of treatment
GB201505465D0 (en) Uses of polymers
TWM490377U (en) Improved structure of C clamp
GB201400436D0 (en) Detection of brain cancer
GB201412124D0 (en) Rapid detection of medical conditions